WJWerner Jaross

Werner Jaross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Werner Jaross has a total of 2 co-authors. Here are the top co-authors by number of shared publications:

  • Mario Menschikowski

    Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technical University of Dresden, Germany

    1 shared publication
  • Rolf Eckey

    Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technical University of Dresden, Germany

    1 shared publication

Latest Publications

  • Biological effects of secretory phospholipase A2 group IIA on lipoproteins and in atherogenesis

    by Werner Jaross, Rolf Eckey, Mario Menschikowski

    Secretory phospholipase A2 group IIA(sPLA2 IIA) can be produced and secreted by various cell types either constitutionally or as an acute‐phase reactant upon stimulation by proinflammatory cytokines. The enzyme prefers phosphatidylethanolamine and phosphatidylserine as substrates. One important biological function may be the hydrolytic destruction of bacterial membranes. It has been demonstrated, however, that sPLA2 can also hydrolyse the phospholipid monolayers of high density lipoprotein (HDL) and low density lipoprotein (LDL) in vitro. Secretory phospholipase A2‐modified LDL show increased affinity to glycosaminoglycans and proteoglycans, a tendency to aggregate, and an enhanced ability to deliver cholesterol to cells. Incubation of cultured macrophages with PLA2‐treated LDL and HDL is associated with increased intracellular lipid accumulation, resulting in the formation of foam cells. Elevated sPLA2(IIA) activity in blood serum leads to an increased clearance of serum cholesterol. Secretory phospholipase A2(IIA) can also be detected in the intima, adventitia and media of the atherosclerotic wall not only in developed lesions but also in very early stages of atherosclerosis. The presence of DNA of Chlamydia pneumoniae, herpes simplex virus, and cytomegalovirus was found to be associated with sPLA2(IIA) expression and other signs of local inflammation. Thus, sPLA2(IIA) appears to be one important link between the lipid and the inflammation hypothesis of atherosclerosis.